Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
International Journal of Particle Therapy|November 28, 2019
Quantifying Proton Fields for Midline Brain Tumors: A Benefit/Cost Analysis of Planning ObjectivesNeil C Estabrook, Ted A Hoene, Paul S Carlin, et al.
The Journal of Supportive Oncology|March 21, 2014
Whole brain radiotherapy for poor prognosis patients with brain metastases: predictably poor resultsNeil C Estabrook, Stephen T Lutz, Cynthia S Johnson, et al.
CNS Oncology|March 18, 2016
Does Graded Prognostic Assessment outperform Recursive Partitioning Analysis in patients with moderate prognosis brain metastases?Neil C Estabrook, Stephen T Lutz, Cynthia S Johnson, et al.
The British Journal of Radiology|November 23, 2017
Dosimetric impact of gastrointestinal air column in radiation treatment of pancreatic cancerNeil C Estabrook, Jonathan B Corn, Marvene M Ewing, et al.
Medical Dosimetry : Official Journal of the American Association of Medical Dosimetrists|September 17, 2016
Role of belly board device in the age of intensity modulated radiotherapy for pelvic irradiationNeil C Estabrook, Gregory K Bartlett, Julia J Compton, et al.
Technology in Cancer Research & Treatment|June 20, 2014
Effect of Scanning Beam for Superficial Dose in Proton TherapyVadim P Moskvin, Neil C Estabrook, Chee-Wai Cheng, et al.
International Journal of Radiation Oncology, Biology, Physics|October 30, 2016
Reirradiation of Recurrent and Second Primary Head and Neck Cancer With Proton TherapyMark W McDonald, Omid Zolali-Meybodi, Stephen J Lehnert, et al.
Oncology|April 22, 2015
Proton Radiotherapy for Midline Central Nervous System Lesions: A Class SolutionNeil C Estabrook, Mark W McDonald, Ted A Hoene, et al.
Free Radical Biology & Medicine|October 25, 2011
Inhibition of NF-κB and DNA double-strand break repair by DMAPT sensitizes non-small-cell lung cancers to X-raysNeil C Estabrook, Helen Chin-Sinex, Anthony J Borgmann, et al.
Free Radical Biology & Medicine|August 8, 2017
DMAPT inhibits NF-κB activity and increases sensitivity of prostate cancer cells to X-rays in vitro and in tumor xenografts in vivoMarc S Mendonca, William T Turchan, Melanie E Alpuche, et al.
Pageof 2